发明名称 |
FORMULATIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF PRE-MCI AND/OR PRE-ALZHEIMER'S CONDITIONS |
摘要 |
In certain embodiments the methods of preventing or delaying the onset of a pre-Alzheimer's condition and/or cognitive dysfunction, and/or ameliorating one or more symptoms of a pre-Alzheimer's cognitive dysfunction, and/or preventing or delaying the progression of a pre-Alzheimer's condition or cognitive dysfunction to Alzheimer's disease, and/or of promoting the processing of amyloid precursor protein (APP) by the non-amyloidogenic pathway are provided. In certain embodiments the methods involve administering, or causing to be administered, to a subject in need thereof certain formulations comprising or more active agent(s) selected from the group consisting of tropisetron disulfiram, honokiol, nimetazepam, and/or derivatives or analogs thereof. |
申请公布号 |
US2015030683(A1) |
申请公布日期 |
2015.01.29 |
申请号 |
US201314378950 |
申请日期 |
2013.02.15 |
申请人 |
BUCK INSTITUTE FOR RESEARCH ON AGING |
发明人 |
John Varghese;Bredesen Dale E.;Tzannis Stelios |
分类号 |
A61K31/439;A61K47/48;A61K31/5513;A61K31/145;A61K31/05 |
主分类号 |
A61K31/439 |
代理机构 |
|
代理人 |
|
主权项 |
1. A prolonged release drug dosage formulation for peroral or oral transmucosal administration comprising a dissolvable drug formulation wherein said formulation comprises:
a predetermined amount of one or more active agent(s) selected from the group consisting of tropisetron disulfiram, honokiol, nimetazepam, and/or derivatives or analogs thereof; and a bioadhesive material, said bioadhesive material providing for adherence to the mucosal membranes of a subject. |
地址 |
NOVATO CA US |